Back
Citius Oncology Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
CTOR
Citius Oncology
Last Price:
$0.69
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and CTOR is experiencing slight selling pressure.
Citius Oncology Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.67 | Buy |
20-day SMA: | 0.7 | Buy |
50-day SMA: | 0.84 | Sell |
200-day SMA: | 0 | Buy |
8-day EMA: | 0.68 | Buy |
20-day EMA: | 0.64 | Buy |
50-day EMA: | 0.45 | Buy |
200-day EMA: | 0.16 | Buy |
Citius Oncology Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.07 | Buy |
Relative Strength Index (14 RSI): | 48.4 | Sell |
Chaikin Money Flow: | -25534 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.63 - 0.77) | Buy |
Bollinger Bands (100): | (0.75 - 1.27) | Sell |
Citius Oncology Technical Analysis
Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Citius Oncology Stock
Is Citius Oncology Stock a Buy?
-
Citius Oncology share price is 0.70 while CTOR 8-day simple moving average is 0.67, which is a Buy signal.
-
The stock price of CTOR is 0.70 while Citius Oncology 20-day SMA is 0.70, which makes it a Buy.
-
Citius Oncology 50-day simple moving average is 0.84 while CTOR share price is 0.70, making it a Sell technically.
-
CTOR stock price is 0.70 and Citius Oncology 200-day simple moving average is 0.00, creating a Buy signal.
CTOR Technical Analysis vs Fundamental Analysis
Sell
37
Citius Oncology (CTOR)
is a Sell
Is Citius Oncology a Buy or a Sell?
-
Citius Oncology stock is rated a SellThe current Citius Oncology [CTOR] share price is $0.70. The Score for CTOR is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Citius Oncology Stock Info
Market Cap:
50.1M
Price in USD:
0.70
Share Volume:
47.7K
Citius Oncology 52-Week Range
52-Week High:
49.00
52-Week Low:
0.55
Sell
37
Citius Oncology (CTOR)
is a Sell
Citius Oncology Share Price Forecast
-
What is the Citius Oncology stock price today?The Citius Oncology stock price is 0.70 USD today.
-
Will CTOR stock go up or go down?Citius Oncology> share price is forecast to RISE/FALL based on technical indicators
-
Is Citius Oncology overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Citius Oncology is overvalued.
Is Citius Oncology Stock a Buy?
-
Citius Oncology share price is 0.70 while CTOR 8-day exponential moving average is 0.68, which is a Buy signal.
-
The stock price of CTOR is 0.70 while Citius Oncology 20-day EMA is 0.64, which makes it a Buy.
-
Citius Oncology 50-day exponential moving average is 0.45 while CTOR share price is 0.70, making it a Buy technically.
-
CTOR stock price is 0.70 and Citius Oncology 200-day simple moving average is 0.16, creating a Buy signal.
Technical Analysis of Citius Oncology
Should I short Citius Oncology stock?
-
CTOR Moving Average Covergence Divergence (MACD) indicator is 0.07, suggesting Citius Oncology is a Buy
-
Citius Oncology Relative Strength Index (RSI) is 48.4, which suggest Citius Oncology is oversold
-
The Bollinger Bands (25) for Citius Oncology is (0.63 - 0.77), which suggest Citius Oncology is a Sell
-
The Bollinger Bands (100) for Citius Oncology is (0.75 - 1.27), which suggest Citius Oncology is a Sell
* Citius Oncology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.